Structure based drug design

From DISI
Revision as of 19:20, 13 September 2007 by JohnIrwin (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Structure based drug design includes virtual screening, but also more low-throughput methods such as having a medicinal chemist just look at a model and propose new compounds to make and test.